Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gsk Plc ADR
(NY:
GSK
)
42.63
+0.68 (+1.62%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gsk Plc ADR
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
33
34
Next >
The 3 Best Market Sectors for the Second Half of 2022
July 27, 2022
Compelling themes will drive a recovery in some sectors over the second half of 2022. The following are the best market sectors to buy into.
Via
InvestorPlace
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
July 27, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Drug Behemoth GSK Delivers Strong Beat And Raise, But Shares Fell
July 27, 2022
The company expects full-year sales to grow 6%-8% and for earnings to rise 1%.
Via
Investor's Business Daily
Jim Cramer Says This Stock Costs About $3, But 'If You Wait Long Enough' You Can Buy It For $2
July 27, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Blackstone Inc. (NYSE: BX) over Apollo Global Management Inc (NYSE: APO).
Via
Benzinga
New GSK Q2 Highlights: Shingles Vaccine Back In Demand, Antibiotics Recover, Forecast Boost
July 27, 2022
Via
Benzinga
Codexis Shares Slide On CEO Transition
July 18, 2022
Via
Benzinga
GSK Completes Spin Off Of Its Consumer Healthcare Business
July 18, 2022
Via
Benzinga
Benzinga Before The Bell: Twitter Shareholder Proposal Date Set, T-Mobile's Strong FY22 Outlook, Shopify's Job Cuts And Other Top Financial Stories Wednesday, July 27
July 27, 2022
Reuters Monkeypox Emergency Could Last Months, According To Experts
Via
Benzinga
7 Dividend Stocks to Buy on the Dip
July 27, 2022
The stock market is volatile and bottoming, making it a good time to buy dividend stocks on the dip. Here are seven worth your consideration.
Via
InvestorPlace
This Analyst Says GSK Spin-Off Haleon Offers "Best Of Both Consumer Worlds"
July 22, 2022
Citi group has initiated coverage on GSK plc's (NYSE: GSK) consumer healthcare spin-off Haleon Plc (NYSE: HLN) with a Buy rating and a price target of 360p.
Via
Benzinga
3 Biotech Stocks to Buy on the Dip
July 21, 2022
Biotech stocks have rebounded lately and are poised to keep surging, so it's a good time to buy biotech stocks on the dip.
Via
InvestorPlace
GSK Shares Encouraging Data From Chronic Hepatitis B Candidate
June 27, 2022
Via
Benzinga
Benzinga Before The Bell: Musk's Twitter Lawsuit, Uber Penalized For Overcharging People With Disabilities, Johnson & Johnson Cuts Outlook And Other Top Financial Stories Tuesday, July 19
July 19, 2022
CNBC Amazon Courts More Trouble As Regulators Inspect Its Warehouses
Via
Benzinga
Post Mega London Stock Exchange Listing, GSK Spinoff Haleon's Plunge Brings Valuation Concerns To The Fore
July 19, 2022
After GSK (NYSE: GSK) spun off its consumer health division Haleon Plc (LSE: HLN) into a separate entity, shares of the newly listed firm plunged during intraday trade, closing over 6.5% down at...
Via
Benzinga
Air Pollution is a Global Heart and Lung Health Concern
July 18, 2022
Palm Beach, FL – July 18, 2022 – FinancialNewsMedia.com News Commentary – Particulate matter or particle pollution is a significant contributor to heart and lung disease. Individuals most affected by...
Via
FinancialNewsMedia
Topics
Climate Change
Emissions
Energy
Exposures
Climate
Fossil Fuels
Benzinga Before The Bell: Amazon Wages Price War On Tesco, Biden's Campaign Promise To Free Cannabis Prisoners, H&M Exits Russia And Other Top Financial Stories Monday, July 18
July 18, 2022
Reuters GSK Completes Spin-Off Of Its Consumer Healthcare Business
Via
Benzinga
The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures
July 14, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Theravance Biopharma, Innoviva Gain On Selling TRELEGY ELLIPTA Royalty Interests
July 13, 2022
Via
Benzinga
Science Wednesday: Where To See Comet K2 As It Passes The Earth
July 13, 2022
Five years ago, astronomers were electrified to confirm the discovery of Comet C/2017 K2, more commonly known as Comet K2. At the time, it was believed to be one of the largest comets zooming across...
Via
Benzinga
The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner
July 12, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
GSK prepares US for 2022-23 flu season with over 50 million influenza vaccine doses
July 11, 2022
From
GSK plc
Via
Business Wire
7 Retirement Stocks to Buy in July
July 01, 2022
Planning for retirement can feel overwhelming in bear markets, but these seven retirement stocks can provide a boost to savings. Caterpillar (CAT): The
Via
InvestorPlace
GSK Selects Target the Future Grant Recipient in Innovation Challenge Supporting Multiple Myeloma Community
June 29, 2022
From
GSK plc
Via
Business Wire
Ideaya Nominates Potential First-In-Class Pol Theta Helicase Inhibitor In Collaboration With GSK
June 28, 2022
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
June 27, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
June 27, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
With Zero Revenue, Laekna Plays Chicken-And-Egg Game With Investors
June 24, 2022
Key Takeaways: Laekna is seeking a Hong Kong IPO to raise funds to accelerate the commercialize two core products licensed from Novartis The company currently is not generating...
Via
Benzinga
Finally An Omicron-Blocking Shot? Sanofi, GSK Say Yes
June 24, 2022
The companies' shot was more than 93% effective in previously infected people.
Via
Investor's Business Daily
Benzinga Before The Bell: Gun Safety Bill. Bill Gates's North Dakota Outrage, Sanofi-GSK's Covid-19 Vaccine's Omicron Efficacy And Other Top Financial Stories Friday, June 24
June 24, 2022
Reuters
Via
Benzinga
Sanofi-GSK's Beta-Containing COVID-19 Vaccine Shows Efficacy Against Omicron
June 24, 2022
Via
Benzinga
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
33
34
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.